RxDoctor Payments Data

Avneet Singh, MD

Cardiovascular Disease · Kew Gardens, NYNPI 1487741872

Payments from drug & device makers

$279,568in general payments, 2019–2025

Across 172 payments — averaging $1625.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$274K
  • Abbott$937
  • Boston Scientific$865
  • Shockwave Medical, Inc$744
  • Edwards Lifesciences$715
  • Cardiovascular Systems Inc.$492
  • plus $2K from 10 others

What the payments were for

  • Food & beverage$10,550100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$279,568 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York

Medicare billing

Part B allowed, 2024
$123,022
Medicare patients
274
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$68,107
EntrestoSacubitril/Valsartan48$44,027
BrilintaTicagrelor11$12,796
Atorvastatin Calcium199$2,582
Metoprolol Succinate127$1,902
Ranolazine ErRanolazine21$1,532
Nifedipine ErNifedipine18$723
ClopidogrelClopidogrel Bisulfate55$548
Losartan Potassium75$526
Ezetimibe16$474
Isosorbide Mononitrate ErIsosorbide Mononitrate41$439
Amlodipine Besylate65$407
Lisinopril84$397
Carvedilol71$384
Metoprolol Tartrate47$298

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Kew Gardens

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →